| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.98B | -3.8% |
| R&D Expense | $177.7M | +8.7% |
| SG&A Expense | $629.7M | -2.1% |
| Operating Income | $537.0M | -1.2% |
| Pre-tax Income | $497.6M | +2.9% |
| Income Tax | $75.4M | -29.3% |
| Net Income | $422.2M | +12.0% |
| EPS (Basic) | $2.76 | +13.6% |
| EPS (Diluted) | $2.75 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $356.4M | +4.5% |
| Accounts Receivable | $526.1M | +5.7% |
| Inventory | $337.8M | +13.9% |
| Current Assets | $1.37B | +2.8% |
| Total Assets | $4.31B | +0.4% |
| Current Liabilities | $909.2M | -4.8% |
| Long-term Debt | $2.09B | -4.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $427.5M | -6.0% |
| Capital Expenditures | $82.7M | +37.6% |
| Investing Cash Flow | -$11.4M | -116.5% |
| Financing Cash Flow | -$392.3M | -1.2% |
| Free Cash Flow | $344.8M | -12.7% |
| +13.6% |
| Total Liabilities |
| $3.25B |
| -4.3% |
| Stockholders' Equity | $1.05B | +18.0% |